- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2015-02-09 16:37:47
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2015-02-09 16:37:47
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|890465||Nps Pharmaceuticals Inc||NPSP||Biological Products, (No Disgnostic Substances) (2836)||870439579|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1299691||J Joseph Rogus||550 Hills Drive |
Bedminster NJ 07921
|Svp, Gto & Supply Chain Mngmt||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Employee Stock Options (right to buy)||Disposition||2015-02-05||16,875||$0.00||16,875||$8.25|
|Common Stock||Employee Stock Options (right to buy)||Disposition||2015-02-05||11,434||$0.00||11,434||$8.23|
|Common Stock||Employee Stock Options (right to buy)||Disposition||2015-02-05||4,313||$0.00||4,313||$3.34|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.89 to $45.93, inclusive. The reporting person undertakes to provide to NPS Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- On February 17, 2011, the reporting person received a grant of 45,000 stock options under the Issuer's 1998 Stock Option Plan. The options became exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
- On February 13, 2013, the reporting person received a grant of 26,136 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options became exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
- On February 19, 2010, the reporting person was granted options to purchase shares of common stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. As of the date of this filing, the performance criteria and the time-based criteria for 112,125 of these options has been satisfied. These options vested and became exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.